Cargando…
m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
Both N6-methyladenosine (m6A) RNA modification and microRNAs (miRNAs) are common regulatory mechanisms for gene post-transcription by modulating mRNA stability and translation. They also share the same 3′-untranslated regions (UTRs) regions for their target gene. However, little is known about their...
Autores principales: | Qian, Benheng, Wang, Ping, Zhang, Donghong, Wu, Lianpin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257704/ https://www.ncbi.nlm.nih.gov/pubmed/34226535 http://dx.doi.org/10.1038/s41420-021-00552-7 |
Ejemplares similares
-
Ferroptosis Associates With Diagnosis and Prognosis by Promoting Antitumor Immune Response in Melanoma
por: Qian, Benheng, et al.
Publicado: (2022) -
Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis
por: Qian, Benheng, et al.
Publicado: (2022) -
Reciprocal repression between Fgf8 and miR-133 regulates cardiac induction through Bmp2 signaling
por: Lopez-Sanchez, Carmen, et al.
Publicado: (2015) -
CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA
por: Yao, Bing, et al.
Publicado: (2022) -
Circulating MiR-133a as a Biomarker Predicts Cardiac Hypertrophy in Chronic Hemodialysis Patients
por: Wen, Ping, et al.
Publicado: (2014)